Survey on the Effectiveness of the PLAB Examination in Continuing Clinical Education in British Doctors.
Launched by JABIR IBN HAYYAN MEDICAL UNIVERSITY · May 2, 2022
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Post-PLAB exam and GMC registration international medical graduate
- • Candidates who practise in NHS as FY1 and FY2
- Exclusion Criteria:
- • Pass PLAB one exam
- • Pass PLAB two exam
- • Candidates pass PLAB one and two but still not working in NHS
About Jabir Ibn Hayyan Medical University
Jabir Ibn Hayyan Medical University is a leading academic institution dedicated to advancing medical education, research, and clinical practice. With a focus on innovative healthcare solutions, the university actively engages in clinical trials to enhance patient care and contribute to the body of medical knowledge. Its multidisciplinary approach fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous study design and ethical conduct. Committed to excellence, Jabir Ibn Hayyan Medical University aims to translate research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Westbury On Severn, West Suffolk, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials